Summary:
Moderate To Severe Ulcerative Colitis
The primary objective of this study is to evaluate the long-term safety and tolerability of an investigational medication in participants with moderate to severe ulcerative colitis (UC).
To qualify, you must:
- Be 18-80 years old
- Diagnosis of UC established at least 3 months prior to enrollment by clinical and endoscopic evidence
Qualified Participants May Receive:
Compensation for time and travel